当前位置:科学网首页 > 小柯机器人 >详情
链转移抑制剂结合下HIV整合体的结构基础获解析
作者:小柯机器人 发布时间:2020/2/10 11:28:55

美国索尔克生物研究所Dmitry Lyumkis研究组的最新工作解析了链转移抑制剂结合下HIV整合体的结构基础。这一研究成果2020年1月30日在线发表于国际学术期刊《科学》。

研究人员报道了结合最新一代的整合酶(IN)链转移抑制剂(INSTI)结合下HIV整合体的高分辨率冷冻电镜(cryo-EM)结构。这些结构凸显出IN活性位点的微小变化对药物结合和设计有何重大影响,并提供了机制性原理的见解,从而证明了最新的INSTI为何仍能抵抗广泛的耐药变异。这些数据对于拓展HIV感染者的有效疗法有促进作用。
 
据悉,HIV整合体是一个巨大的核蛋白装配体,其介导病毒基因组DNA拷贝整合到宿主染色质中。最新一代的抗逆转录病毒INSTI靶向整合体。慢病毒整合体生化相关的难题阻碍了对INSTI如何与其天然药物靶标结合的高分辨结构研究。
 
附:英文原文

Title: Structural basis for strand transfer inhibitor binding to HIV intasomes

Author: Dario Oliveira Passos, Min Li, Ilona K. Jówik, Xue Zhi Zhao, Diogo Santos-Martins, Renbin Yang, Steven J. Smith, Youngmin Jeon, Stefano Forli, Stephen H. Hughes, Terrence R. Burke, Robert Craigie, Dmitry Lyumkis

Issue&Volume: 2020/01/30

Abstract: AbstractThe HIV intasome is a large nucleoprotein assembly that mediates the integration of a DNA copy of the viral genome into host chromatin. Intasomes are targeted by the latest generation of antiretrovirals, integrase (IN) strand transfer inhibitors (INSTIs). Challenges associated with lentiviral intasome biochemistry have hindered high-resolution structural studies of how INSTIs bind to their native drug target. Here, we present high-resolution cryo-electron microscopy (cryo-EM) structures of HIV intasomes bound to the latest generation INSTIs. These structures highlight how small changes in the IN active site can have significant implications for drug binding and design and provide mechanistic insights into why a leading INSTI retains efficacy against a broad spectrum of drug resistant variants. The data have implications for expanding effective treatments available for HIV-infected individuals.

DOI: 10.1126/science.aay8015

Source: https://science.sciencemag.org/content/early/2020/01/29/science.aay8015

期刊信息
Science:《科学》,创刊于1880年。隶属于美国科学促进会,最新IF:41.037